InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the full record of transactions filed by Froimson Mark, Director. Officer active across 1 company, notably Pacira BioSciences, Inc.. Cumulatively, 6 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €56k. History available since 9 June 2021. The latest transaction was disclosed on 8 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
1,160 shares0Common StockSEC:0001209191-22-035218:0
1,000 shares@ US$59.370.0053% mcap100.0% of flowCommon StockSEC:0001209191-22-028275:0
400 shares0Common StockSEC:0001209191-21-070553
400 shares0Common StockSEC:0001209191-21-070553:0
1,066 shares0Common StockSEC:0001209191-21-040082:0
1,066 shares0Common StockSEC:0001209191-21-040082
6 of 6 declarations
About Froimson Mark
Mark Froimson is a Board Member at Pacira BioSciences, Inc. He brings expertise in corporate governance and business strategy. His role is crucial in guiding strategic decisions and ensuring compliance with regulatory standards.
